Reports Net Investment Income of $0.47 Per Share and Net Asset Value of $18.85 Per Share Deployment of Approximately $17.5 Million and Sales and Repayments of Approximately $15.7 Million for Net Deployment of Approximately $1.8 Million Announces Second Quarter 2025 Quarterly Base Distribution of $0.47 Per Share Investors are Encouraged to Vote FOR the Acquisition of Logan Ridge Finance Corporation NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or ...

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter ended March 31, 2025. Business Update Silvercrest experienced strong new client organic flows of $0.4 billion during the first quarter of 2025. The new assets under management (“AUM”) follow on the significant new client flows of $1.4 billion in the 4th quarter of 2024. Our first quarter’s new client account flows was ...

Quarter Sales of $135.4 million, up 42% from a year earlier, Quarter Gross Margin of 29.7%, up 2.7% from a year earlier, Quarter Net Income of $19.1 million, up 168% from a year earlier, EPS $0.83 for the Quarter, Debt decreased $10.0 million. WOOD DALE, Ill, May 08, 2025 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (the "Company" or "PSI") (Nasdaq: PSIX), a leader in the design, engineering and manufacture of emission- certified engines and power systems, announced its financial results for the ...

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) -- AlphaGen Intelligence Corp. (CSE: AIC | OTC: APETF | FSE: W4V) (“AlphaGen'' or the “Company”) is pleased to announce a non-brokered private placement offering (the “Offering”) consisting of up to an aggregate 2,437,500 units of the company (each, a “Unit”) at a price of $0.08 per Unit for gross proceeds of up to $195,000. Each Unit consists of ...

Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced its financial results for ...

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Quartzsea Acquisition Corp (Nasdaq: QSEAU, the “Company”) announced that, holders of the 8,280,000 units sold in the Company’s initial public offering may elect to separately trade the ordinary shares and rights included in the units, commencing on or about May 12, 2025. Any units not separated will continue to trade on the Nasdaq Global Market (the “Nasdaq”) under the symbol “QSEAU,” and the separated ordinary shares and rights are expected to trade on the Nasdaq ...

Lists as public company on the NASDAQ under the ticker TWNP Completes second company-owned Smokey Bones conversion to Twin Peaks Lodge in Brandon, Florida Opens new franchised Twin Peaks Lodge in Algonquin, Illinois Hosting conference call and webcast today at 5:15 PM ET DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Twin Hospitality Group Inc. (NASDAQ: TWNP) (“Twin Peaks” or the “Company”) today reported financial results for the fiscal first quarter ended March 30, 2025. “Our strong operational foundation, inno ...

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust (TSX-AD.UN) (together, as applicable, with its subsidiaries, “Alaris” or the "Trust") is pleased to announce its results for the three months ended March 31, 2025. The results are prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Stan ...

- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization - - Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO-006 programs presented at AACR 2025 and PEGS, respectively - - Three INDs for wholly-owned programs anticipated in next 3 years, beginning with potential best-in-class Tissue Factor ADC, STRO-004, planned for 2H 2025 - - IND-enabling toxicology study ongoing for one program within Astellas iADC ...

Core Viewpoint - Theriva Biologics has successfully closed a public offering, raising approximately $7.5 million to support its cancer therapeutics development and other corporate purposes [1][2]. Group 1: Offering Details - The public offering consisted of 6,818,180 shares of common stock and warrants to purchase an equal number of shares at a combined price of $1.10 per share [1]. - The warrants are exercisable immediately and will expire five years from the issuance date [1]. - The offering was conducted under a registration statement that was declared effective by the SEC on May 7, 2025 [3]. Group 2: Use of Proceeds - The net proceeds from the offering will primarily be used for working capital, general corporate purposes, research and development, and manufacturing scale-up [2]. - The company may also consider investing in or acquiring other products, businesses, or technologies, although no commitments currently exist [2]. Group 3: Company Overview - Theriva Biologics is a clinical-stage company focused on developing therapeutics for cancer and related diseases, with a particular emphasis on high unmet medical needs [5]. - The company's lead candidates include VCN-01, SYN-004, and SYN-020, targeting various aspects of cancer treatment and gastrointestinal health [5].